{"id":"NCT00443820","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail","officialTitle":"A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Topical Terbinafine Hydrogen Chloride (HCl) Formulation for 24 or 48 Weeks of Treatment in Patients With Mild to Moderate Toenail Onychomycosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2008-06","completion":"2008-06","firstPosted":"2007-03-06","resultsPosted":"2011-04-19","lastUpdate":"2011-04-19"},"enrollment":526,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Onychomycosis"],"interventions":[{"type":"DRUG","name":"terbinafine","otherNames":["Lamisil"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"terbinafine","otherNames":["Lamisil"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"},{"label":"3","type":"EXPERIMENTAL"},{"label":"4","type":"PLACEBO_COMPARATOR"}],"summary":"This study is designed to assess the efficacy, safety and tolerability of a topical formulation of terbinafine solution applied daily in patients with toenail fungus. This trial will study patients with mild to moderate toenail fungus disease of the big toenail and their responses to two treatment durations, 24 or 48 weeks.","primaryOutcome":{"measure":"Efficacy Assessed by the Percentage of Participants With Complete Cure at the End of Study (Week 52) After Treating for 24 or 48 Weeks","timeFrame":"52 weeks","effectByArm":[{"arm":"Terbinafine 24 Weeks","deltaMin":1.5,"sd":null},{"arm":"Vehicle 24 Weeks","deltaMin":0.77,"sd":null},{"arm":"Terbinafine 48 Weeks","deltaMin":2.96,"sd":null},{"arm":"Vehicle 48 Weeks","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":23,"countries":["United States","France","Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":131},"commonTop":["Headache","Nasopharyngitis","Back pain","Influenza","Upper respiratory tract infection"]}}